Paxton WA - Search Results

1

Optimization of human immunodeficiency virus type 1 envelope glycoproteins with V1/V2 deleted, using virus evolution.

Bontjer I, Land A, Eggink D, Verkade E, Tuin K, Baldwin C, Pollakis G, Paxton WA, Braakman I, Berkhout B, Sanders RW. Bontjer I, et al. Among authors: paxton wa. J Virol. 2009 Jan;83(1):368-83. doi: 10.1128/JVI.01404-08. Epub 2008 Oct 15. J Virol. 2009. PMID: 18922866 Free PMC article.

2

N-linked glycosylation of the HIV type-1 gp120 envelope glycoprotein as a major determinant of CCR5 and CXCR4 coreceptor utilization.

Pollakis G, Kang S, Kliphuis A, Chalaby MI, Goudsmit J, Paxton WA. Pollakis G, et al. Among authors: paxton wa. J Biol Chem. 2001 Apr 20;276(16):13433-41. doi: 10.1074/jbc.M009779200. Epub 2001 Jan 16. J Biol Chem. 2001. PMID: 11278567 Free article.

3

Identification of sequential viral escape mutants associated with altered T-cell responses in a human immunodeficiency virus type 1-infected individual.

Geels MJ, Cornelissen M, Schuitemaker H, Anderson K, Kwa D, Maas J, Dekker JT, Baan E, Zorgdrager F, van den Burg R, van Beelen M, Lukashov VV, Fu TM, Paxton WA, van der Hoek L, Dubey SA, Shiver JW, Goudsmit J. Geels MJ, et al. Among authors: paxton wa. J Virol. 2003 Dec;77(23):12430-40. doi: 10.1128/jvi.77.23.12430-12440.2003. J Virol. 2003. PMID: 14610167 Free PMC article.

4

Intrapatient alterations in the human immunodeficiency virus type 1 gp120 V1V2 and V3 regions differentially modulate coreceptor usage, virus inhibition by CC/CXC chemokines, soluble CD4, and the b12 and 2G12 monoclonal antibodies.

Nabatov AA, Pollakis G, Linnemann T, Kliphius A, Chalaby MI, Paxton WA. Nabatov AA, et al. Among authors: paxton wa. J Virol. 2004 Jan;78(1):524-30. doi: 10.1128/jvi.78.1.524-530.2004. J Virol. 2004. PMID: 14671134 Free PMC article.

5

Phenotypic and genotypic comparisons of CCR5- and CXCR4-tropic human immunodeficiency virus type 1 biological clones isolated from subtype C-infected individuals.

Pollakis G, Abebe A, Kliphuis A, Chalaby MI, Bakker M, Mengistu Y, Brouwer M, Goudsmit J, Schuitemaker H, Paxton WA. Pollakis G, et al. Among authors: paxton wa. J Virol. 2004 Mar;78(6):2841-52. doi: 10.1128/jvi.78.6.2841-2852.2004. J Virol. 2004. PMID: 14990703 Free PMC article.

6

Broad cross-clade T-cell responses to gag in individuals infected with human immunodeficiency virus type 1 non-B clades (A to G): importance of HLA anchor residue conservation.

Geels MJ, Dubey SA, Anderson K, Baan E, Bakker M, Pollakis G, Paxton WA, Shiver JW, Goudsmit J. Geels MJ, et al. Among authors: paxton wa. J Virol. 2005 Sep;79(17):11247-58. doi: 10.1128/JVI.79.17.11247-11258.2005. J Virol. 2005. PMID: 16103177 Free PMC article.

7

Lewis X component in human milk binds DC-SIGN and inhibits HIV-1 transfer to CD4+ T lymphocytes.

Naarding MA, Ludwig IS, Groot F, Berkhout B, Geijtenbeek TB, Pollakis G, Paxton WA. Naarding MA, et al. Among authors: paxton wa. J Clin Invest. 2005 Nov;115(11):3256-64. doi: 10.1172/JCI25105. Epub 2005 Oct 20. J Clin Invest. 2005. PMID: 16239964 Free PMC article.

8

CTL escape and increased viremia irrespective of HIV-specific CD4+ T-helper responses in two HIV-infected individuals.

Geels MJ, Jansen CA, Baan E, De Cuyper IM, van Schijndel GJ, Schuitemaker H, Goudsmit J, Pollakis G, Miedema F, Paxton WA, van Baarle D. Geels MJ, et al. Among authors: paxton wa. Virology. 2006 Feb 5;345(1):209-19. doi: 10.1016/j.virol.2005.09.023. Epub 2005 Oct 21. Virology. 2006. PMID: 16246391 Free article.

9

Bile salt-stimulated lipase from human milk binds DC-SIGN and inhibits human immunodeficiency virus type 1 transfer to CD4+ T cells.

Naarding MA, Dirac AM, Ludwig IS, Speijer D, Lindquist S, Vestman EL, Stax MJ, Geijtenbeek TB, Pollakis G, Hernell O, Paxton WA. Naarding MA, et al. Among authors: paxton wa. Antimicrob Agents Chemother. 2006 Oct;50(10):3367-74. doi: 10.1128/AAC.00593-06. Antimicrob Agents Chemother. 2006. PMID: 17005819 Free PMC article.

10

Interaction of HIV-1 with dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin-expressing cells is influenced by gp120 envelope modifications associated with disease progression.

Nabatov AA, van Montfort T, Geijtenbeek TB, Pollakis G, Paxton WA. Nabatov AA, et al. Among authors: paxton wa. FEBS J. 2006 Nov;273(21):4944-58. doi: 10.1111/j.1742-4658.2006.05491.x. Epub 2006 Sep 28. FEBS J. 2006. PMID: 17010165 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Search Page

Filters